prevymis - letermovir tablet, film coated
(Letermovir)Merck Sharp & Dohme Llc
Usage: Prevymis prevents cytomegalovirus (CMV) infection and disease in CMV-seropositive adults and children (6 months+, ≥6 kg) receiving an allogeneic stem cell transplant, and in adults and adolescents (12 years+, ≥40 kg) who are high-risk kidney transplant recipients (CMV-positive donor, CMV-negative recipient).